期刊文献+

洋川芎内酯Ⅰ大鼠在体肠吸收动力学研究 被引量:4

In situ Intestinal Absorption Kinetics of Senkyunolide Ⅰ in Rats
原文传递
导出
摘要 目的研究洋川芎内酯I大鼠在体肠吸收特性。方法运用大鼠在体单向灌流技术考察洋川芎内酯Ⅰ在大鼠4个肠段的吸收动力学特征;采用高效液相色谱法(HPLC)测定灌流液中洋川芎内酯I的含量;从药物质量浓度、吸收部位、灌流介质3个方面对洋川芎内酯I的各肠段吸收特性进行考察;利用重量法计算动力学参数。结果不同质量浓度(514、257和128.5μg.mL-1)洋川芎内酯Ⅰ在相同肠段的吸收速率常数ka和表观吸收系数Papp均无显著性差异(P>0.05);十二指肠段的表观吸收系数Papp与空肠、回肠和结肠均有极显著性差异(P<0.001),而空肠、回肠、结肠间均无显著性差异。结论洋川芎内酯I在大鼠肠道的吸收在所选剂量范围内呈线性动力学过程,提示其吸收可能以被动转运为主;在大鼠各肠段均有较好吸收,其中十二指肠为其最佳吸收部位。 OBJECTIVE To study the in situ intestinal absorption kinetics of senkyunolide I in rats. METHODS The absorption of senkyunolide I in four segments of rat intestine was investigated using the in situ single-pass perfusion method, and the drug content was measured by HPLC. The absorption kinetics of senkyunolide I at different segments of intestine, drug concentration, and perfusion medium were studied. RESULTS Drug concentration had no significant influence on the ka and the P app, values of senkyunolide I (P 〉 0. 05 ) in the range of 128.5 -514 μg mL-1. Papp values of senkyunolide I at duodenum were significantly higher than those at the other three regions of intestine ( P 〈 0. 001 ). But no significant differences in the Papp value ( P 〉 0. 05 ) were found among jeju- num, ileum, and colon. CONCLUSION The absorption of senkyunolide I complied with linear kinetics in the dose range studied, indicating that its absorption may be mediated mainly by passive transport. Senkyunolide I could be absorbed at all the studied intesti- nal segments while duodenum seemed to be the best absorption segment for it.
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第8期628-632,共5页 Chinese Pharmaceutical Journal
基金 国家教育部科学技术研究重点项目(211060) 上海市科委上海市自然科学基金项目(11ZR1434500) 上海市教委重点学科项目(J50302) 上海市教育委员会科研创新项目重点项目(11zz112,12ZZ124)
关键词 洋川芎内酯Ⅰ 肠吸收 重量法 药剂学 senkyunolide I intestinal absorption gravimetric method pharmaceutics
  • 相关文献

参考文献3

二级参考文献19

  • 1李松林,林鸽,钟凯声,谭润球.应用HPLC-DAD-MS联用技术研究中药川芎指纹图谱[J].药学学报,2004,38(8):621-626. 被引量:58
  • 2李作洲,徐艳琴,王瑛,黄宏文.淫羊藿属药用植物的研究现状与展望[J].中草药,2005,36(2):289-295. 被引量:94
  • 3孙蓉,吕丽莉,刘国卿.芍药苷对沙土鼠不全性脑缺血后能量代谢、NO和NOS的影响[J].中国中药杂志,2006,31(10):832-835. 被引量:18
  • 4Ch.P Vol I(中国药典2005年版.一部)[S].2005:229.
  • 5ZHAO Y H, ABRAHAM M H, LE J, et al. Evaluation of rat intestinal absorption data and correlation with human intestinal absorption [ J ]. Eur J Med Chem, 2003,38 (3) :233-243.
  • 6CHEN J, LIN H M, HUM. Metabolism of flavonoids via enteric recycling: Role of intestinal disposition[ J]. J Pharm Exp Ther, 2003,304 ( 3 ) : 1228-1235.
  • 7LIU Y, LIU Y. Enteric Disposition and Recycling of Flavonoids and Ginkgo Elavonoids [ J ]. J Altern Complement Med, 2003,9 (5) :631-640.
  • 8JIA X B, CHEN J, LIN H M, et al. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of Biochanin A and Formononetin and excretion of their phase II conjugates[ J]. J Pharm Exp Ther,2004,310 (3) : 1103-1113.
  • 9Wang X, Wei Y, Yuan S, Lu Y, et al. Potential anticancer activity of tanshinone Ⅱ A against human breast cancer [ J ]. Int. J. Cancer, 2005, 116(5) : 799.
  • 10Kim HH, Kim JH, Kwak HB, et al. Inhibition of osteoclast differentiation and bone resorption by tanshinone Ⅱ A isolated from Salvia mihiorrhiza Bunge [ J ]. Biochem Pharmacol 2004, 67 (9) : 1647.

共引文献86

同被引文献44

引证文献4

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部